Literature DB >> 15385466

The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.

Richard W Stokes1, Raymond Norris-Jones, Donald E Brooks, Terry J Beveridge, Dan Doxsee, Lisa M Thorson.   

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, is a facultative intracellular pathogen that infects macrophages and other host cells. We show that sonication of M. tuberculosis results in the removal of material from the surface capsule-like layer of the bacteria, resulting in an enhanced propensity of the bacteria to bind to macrophages. This effect is observed with disparate murine and human macrophage populations though, interestingly, not with freshly explanted alveolar macrophages. Enhanced binding to macrophages following sonication is significantly greater within members of the M. tuberculosis family (pathogens) than within the Mycobacterium avium complex (opportunistic pathogens) or for Mycobacterium smegmatis (saprophyte). Sonication does not affect the viability or the surface hydrophobicity of M. tuberculosis but does result in changes in surface charge and in the binding of mannose-specific lectins to the bacterial surface. The increased binding of sonicated M. tuberculosis was not mediated through complement receptor 3. These results provide evidence that the surface capsule on members of the M. tuberculosis family may be an important virulence factor involved in the survival of M. tuberculosis in the mammalian host. They also question the view that M. tuberculosis is readily ingested by any macrophage it encounters and support the contention that M. tuberculosis, like many other microbial pathogens, has an antiphagocytic capsule that limits and controls the interaction of the bacterium with macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385466      PMCID: PMC517526          DOI: 10.1128/IAI.72.10.5676-5686.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  Entry mechanisms of mycobacteria.

Authors:  S H El-Etr; J D Cirillo
Journal:  Front Biosci       Date:  2001-06-01

Review 2.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

3.  Electron microscopy of ultra-thin sections of lepra cells and Mycobacterium leprae.

Authors:  T YAMAMOTO; M NISHIURA; N HARADA; T IMAEDA
Journal:  Int J Lepr       Date:  1958 Jan-Mar

4.  The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells.

Authors:  Luiz E Bermudez; Felix J Sangari; Peter Kolonoski; Mary Petrofsky; Joseph Goodman
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages.

Authors:  R W Stokes; D Doxsee
Journal:  Cell Immunol       Date:  1999-10-10       Impact factor: 4.868

6.  Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo.

Authors:  J R Schwebach; A Casadevall; R Schneerson; Z Dai; X Wang; J B Robbins; A Glatman-Freedman
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo.

Authors:  J Reid Schwebach; Aharona Glatman-Freedman; Leslie Gunther-Cummins; Zhongdong Dai; John B Robbins; Rachel Schneerson; Arturo Casadevall
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

8.  Utilization of CD11b knockout mice to characterize the role of complement receptor 3 (CR3, CD11b/CD18) in the growth of Mycobacterium tuberculosis in macrophages.

Authors:  M D Melo; I R Catchpole; G Haggar; R W Stokes
Journal:  Cell Immunol       Date:  2000-10-10       Impact factor: 4.868

Review 9.  Genetic bases and medical relevance of capsular polysaccharide biosynthesis in pathogenic streptococci.

Authors:  D Llull; R López; E García
Journal:  Curr Mol Med       Date:  2001-09       Impact factor: 2.222

10.  Deficiency in mycolipenate- and mycosanoate-derived acyltrehaloses enhances early interactions of Mycobacterium tuberculosis with host cells.

Authors:  Cécile Rousseau; Olivier Neyrolles; Yann Bordat; Stéphanie Giroux; Tatiana D Sirakova; Marie-Christine Prevost; Pappachan E Kolattukudy; Brigitte Gicquel; Mary Jackson
Journal:  Cell Microbiol       Date:  2003-06       Impact factor: 3.715

View more
  53 in total

1.  Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.

Authors:  Xian Yu; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Katherine Sosa; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

2.  Microfluidic one-step synthesis of alginate microspheres immobilized with antibodies.

Authors:  Wanyu Chen; Jong-Hoon Kim; Di Zhang; Kyong-Hoon Lee; G A Cangelosi; S D Soelberg; C E Furlong; Jae-Hyun Chung; Amy Q Shen
Journal:  J R Soc Interface       Date:  2013-08-21       Impact factor: 4.118

Review 3.  Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Authors:  Jacqueline M Achkar; Rafael Prados-Rosales
Journal:  Curr Opin Immunol       Date:  2018-04-12       Impact factor: 7.486

4.  Microscopic cords, a virulence-related characteristic of Mycobacterium tuberculosis, are also present in nonpathogenic mycobacteria.

Authors:  Esther Julián; Mónica Roldán; Alejandro Sánchez-Chardi; Oihane Astola; Gemma Agustí; Marina Luquin
Journal:  J Bacteriol       Date:  2010-01-22       Impact factor: 3.490

5.  Capsular glucan and intracellular glycogen of Mycobacterium tuberculosis: biosynthesis and impact on the persistence in mice.

Authors:  Tounkang Sambou; Premkumar Dinadayala; Gustavo Stadthagen; Nathalie Barilone; Yann Bordat; Patricia Constant; Florence Levillain; Olivier Neyrolles; Brigitte Gicquel; Anne Lemassu; Mamadou Daffé; Mary Jackson
Journal:  Mol Microbiol       Date:  2008-09-18       Impact factor: 3.501

6.  Crystal structure of full-length Mycobacterium tuberculosis H37Rv glycogen branching enzyme: insights of N-terminal beta-sandwich in substrate specificity and enzymatic activity.

Authors:  Kuntal Pal; Shiva Kumar; Shikha Sharma; Saurabh Kumar Garg; Mohammad Suhail Alam; H Eric Xu; Pushpa Agrawal; Kunchithapadam Swaminathan
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

7.  Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.

Authors:  Mamadou Daffé; Dean C Crick; Mary Jackson
Journal:  Microbiol Spectr       Date:  2014

8.  Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins.

Authors:  Musa Sani; Edith N G Houben; Jeroen Geurtsen; Jason Pierson; Karin de Punder; Maaike van Zon; Brigitte Wever; Sander R Piersma; Connie R Jiménez; Mamadou Daffé; Ben J Appelmelk; Wilbert Bitter; Nicole van der Wel; Peter J Peters
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  Increased phagocytosis of Mycobacterium marinum mutants defective in lipooligosaccharide production: a structure-activity relationship study.

Authors:  Laeticia Alibaud; Jakub Pawelczyk; Laila Gannoun-Zaki; Vipul K Singh; Yoann Rombouts; Michel Drancourt; Jaroslaw Dziadek; Yann Guérardel; Laurent Kremer
Journal:  J Biol Chem       Date:  2013-11-14       Impact factor: 5.157

10.  Downregulation of protein kinase C-alpha enhances intracellular survival of Mycobacteria: role of PknG.

Authors:  Shivendra K Chaurasiya; Kishore K Srivastava
Journal:  BMC Microbiol       Date:  2009-12-24       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.